Retic Study Group (Rafaximin-Eir-Treatment in Crohn’s Disease). Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderatley Active Crohn’s Disease - Prantera, C; Lochs, H; Grimaldi, M (Gastroenterology, 2012)
et al.